Financial results - NOVOGYN SRL

Financial Summary - Novogyn Srl
Unique identification code: 27923911
Registration number: J12/85/2011
Nace: 6820
Sales - Ron
240.278
Net Profit - Ron
71.299
Employees
1
Open Account
Company Novogyn Srl with Fiscal Code 27923911 recorded a turnover of 2024 of 240.278, with a net profit of 71.299 and having an average number of employees of 1. The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novogyn Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 119.998 200.104 239.468 240.300 239.759 239.995 239.040 240.173 240.310 240.278
Total Income - EUR 120.768 203.664 239.470 249.000 239.761 239.995 239.040 240.173 240.310 240.278
Total Expenses - EUR 132.699 137.473 122.230 126.264 106.511 107.240 103.317 110.089 132.635 162.131
Gross Profit/Loss - EUR -11.931 66.192 117.240 122.736 133.251 132.755 135.722 130.083 107.675 78.147
Net Profit/Loss - EUR -11.931 66.192 106.452 120.246 130.860 130.534 133.619 127.729 105.632 71.299
Employees 0 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 0.5%, from 240.310 euro in the year 2023, to 240.278 euro in 2024. The Net Profit decreased by -33.742 euro, from 105.632 euro in 2023, to 71.299 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Novogyn Srl

Rating financiar

Financial Rating -
NOVOGYN SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novogyn Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novogyn Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novogyn Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novogyn Srl - CUI 27923911

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 907.939 915.307 844.287 772.719 719.494 668.292 615.960 595.941 572.974 546.952
Current Assets 26.803 9.530 1.233 608 1.535 7.557 56.841 42.597 89.287 124.022
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 14.710 2.266 783 381 381 260 1.611 4.526 7.555 2.441
Cash 12.094 7.264 451 227 1.153 7.297 55.230 38.071 81.732 121.581
Shareholders Funds -166.390 -98.502 10.170 130.229 258.567 384.199 509.298 382.467 486.939 414.794
Social Capital 90 89 88 86 84 83 81 81 81 80
Debts 1.101.443 1.023.739 835.754 643.495 462.767 292.013 163.806 256.409 208.279 256.578
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 124.022 euro in 2024 which includes Inventories of 0 euro, Receivables of 2.441 euro and cash availability of 121.581 euro.
The company's Equity was valued at 414.794 euro, while total Liabilities amounted to 256.578 euro. Equity decreased by -69.424 euro, from 486.939 euro in 2023, to 414.794 in 2024.

Risk Reports Prices

Reviews - Novogyn Srl

Comments - Novogyn Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.